openPR Logo
Press release

Sri Lanka Mutual Fund Sector preforming Health Growth Of 10% In Recent Years

07-08-2017 01:52 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Kuick Resarch

Sri Lanka Mutual Fund Sector preforming Health Growth Of 10%

“Sri Lanka Mutual Fund Sector Opportunity Outlook 2022” report highlights:

* Sri Lanka Financial Sector Overview
* Sri Lanka Unit Trust/Mutual Fund Market Overview
* Types of Unit Trusts/ Mutual Funds
* Funds and Fund Managers
* Rules for Unit Trust/ Mutual Fund Companies

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Download Report: https://www.kuickresearch.com/report-sri-lanka-mutual-fund-market-opportunity-outlook-2022.php

Report Table of Contents

What are Unit Trusts (Mutual Fund)?

Types of Unit Trusts (Mutual Funds) in Sri Lanka
2.1 Types of Funds
2.1.1 Open Ended Funds
2.1.2 Closed Ended Funds
2.2 Types of Trust Units
2.2.1 Gilt Edged Funds
2.2.2 Indexed Funds
2.2.3 Income Funds or High Yield Funds
2.2.4 Balanced Funds
2.2.5 Growth Funds
2.2.6 Money Market Fund
2.2.7 Sector Funds
2.2.8 Sharia Funds

Sri Lanka Financial Sector Overview

Sri Lanka Unit Trust Market Overview
4.1 Current Market Scenario
4.2 Market Indicators

Funds and Fund Managers in Sri Lanka Unit Trust Market
5.1 Ceylon Asset Management Company Limited
5.2 Com Trust Asset Management (Private) Limited

Foreign Investment in Sri Lanka Unit Trust (Mutual Fund) Market

7. Sri Lanka Unit Trust Market Regulatory Authorities
7.1 Security and Exchange Commission
7.2 Unit Trust Association of Sri Lanka
7.3 Central Bank of Sri Lanka

Rules for Unit Trust/ Mutual Fund Companies in Sri Lanka

Sri Lanka Unit Trust Market Dynamics
9.1 Improved Economy
9.2 Government initiatives to the develop the industry
9.3 Demographic Factor
9.4 Digital Revolution

Sri Lanka Unit Trust Market Challenges

Sri Lanka Unit Trust Market PEST Analysis
11.1 Political Environment
11.2 Economic Environment
11.3 Social Environment
11.4 Technological Environment

Sri Lanka Unit Trust Market Future Forecasts 2022

Competitive Landscape
13.1 Ceylon Asset Management
13.2 Comtrust Asset Management (Pvt.) Limited
13.3 NDB Wealth Management Limited
13.4 Ceybank Asset Management (Pvt.) Limited
13.5 National Asset Management Limited
13.6 First Capital Asset Management Limited
13.7 Capital Alliance Limited
13.8 Candor Asset Management Pvt. Limited
13.9 Asset Trust Management
13.10 Guardian Acuity Asset management (Pvt.) Limited

Licensed Finance Companies and Specialized Leasing Companies Statistics
14.1 Indicators
14.1.1 Capital Adequacy Ratio
14.1.2 Asset Quality
14.1.3 Profitability
14.1.4 Liquidity
14.2 Assets, Liabilities and Capital
14.2.1 Earnings and Profits

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sri Lanka Mutual Fund Sector preforming Health Growth Of 10% In Recent Years here

News-ID: 615041 • Views: 819

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 35 Billion By 2026
Global cell therapy market is expected to surpass US$ 35 Billion by 2026 as per recent report “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” published by Kuick Research. Increasing investment, gaining research and development activities along with new technological advancement will drive the global cell therapy market. Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-clinical-trials,-therapy-price-and-opportunity-insight-2026.php “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” Report Highlights: • Global Cell Therapy
Cell Therapy Market Size Growth Cell Therapy Clinical Trials Market Forecast 202 …
Cell therapies are still in the infancy stages of the clinical development and are expected to evolve in the market with a vast number of opportunities in the healthcare industry. In order to form a stable base for process evaluation and development it will be essential to understand the quality of cell based products. With an increasing number of cell therapies and clinical indications being assessed, it is clear that
Global Cell Therapy Market Size Analysis Clinical Trials Growth Forecast 2026
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
CAR T Cell Therapy Changing The Cancer Oncology Drug Market Landscape
" Global CAR T Cell Therapy Market & Clinical Trials Insight 2024" Report Highlights: • CAR T-Cell Therapies Delivery Pipeline & Mechanism of Action • Sales Analysis of CAR - T Cell Therapy • CAR - T Cell Therapy Market Opportunity: US$ 700 Million • CAR-T Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies • CAR-T Cell Therapies in Highest Phase: Preclinical • Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) • Global Market Scenario of

All 5 Releases


More Releases for Fund

Templar Fund: March Trade ROE is 2.667%
The Templar Fund, a publicly transparent Bitcoin hedge fund, has released the results of their most recent trade cycle; 
 Trade Cycle Dates: February 19, 2019 - March 20, 2019 The total trade activity ROE: 2.667% Performance Fees: 20.00 % Total Cycle Client ROE:
Direct vs Fund Investments: HNW Preferences
Summary Globally, 44% of HNW wealth is held via funds as opposed to directly. However, there are significant regional differences when it comes to investment preferences. For example, HNW investors in the US, and to a lesser extent in Western Europe, are significantly more likely to invest in funds than their peers in Central and Eastern Europe, Asia Pacific, and the Middle East. Furthermore, while equity funds prevail across the globe,
Koyal Group Creates AIM Index Fund
Tokyo Based Equity Researcher Koyal Group will create a diversified AIM fund in order to create a safe long term investment for clients, taking advantages of numerous tax benefits. Jul. 26, 2013 - TOKYO, Japan -- Koyal Group believes that there is huge profit potential in the FTSE´s Alternative Investment Market (AIM) and will create an actively managed fund to invest into the market. The AIM is comprised of startup companies
BAS Closes Successfully its Second Fund Raising
Box Automation Solutions (BAS), a French company specialized in cash management audit, and treasury solutions via the SWIFT network, announces a new round of financing funded by Middle East Venture Partners (MEVP) a MENA focused venture capital firm covering the Levant and GCC countries. France, Paris, February 08, 2012 -- Box Automation Solutions (BAS), a French company specialized in cash management audit, and treasury solutions via the SWIFT network, announces a
Executives Launch New Healthcare and Insurance Fund
KANSAS CITY, MISSOURI, June 11 --Tom Grant, former Chief Executive Officer of LabOne, and Bill Grant, former Vice President of Sales at LabOne, announce the launch of their investment firm, Haakon Capital. The new firm will focus its activities on making investments in private healthcare and insurance distribution. “We have a solid track record of creating value in healthcare and insurance and we continue to see large
Sanad Sukuk Fund launched in Zurich
The world’s first GCC oriented Sukuk fund, the Islamic counterpart of the conventional bond fund, was officially launched by the fund’s chairman Sheikh Mohammed H. Abudawood, a respected Saudi-based businessmen during the International Islamic Finance Forum in Zurich, 13-16 November. Sheikh Mohammed was pleased to explain the fund’s rationale, saying it closed a wide gap in the Islamic financial industry. At the launch he said “Sukuk as replacement of bonds